What question did this study set out to answer?

To evaluate the clinical risk factors, treatments, and visual outcomes of central retinal vein occlusion (CRVO) in patients younger than 40 years.

August 4, 2023Frontiers in MedicineOpen Access

Central retinal vein occlusion in young population: risk factors and outcomes

View Full Paper

Ask AI

Bookmark

Authors

JBJordan BerguigFondation de Rothschild YAYoussef AbdelmassihSaint Joseph University GAGeorges AzarFondation de Rothschild

Discussion

Member takes

Implication

Retrospective case series reveals identifiable risk factors in most young central retinal vein occlusion cases, indicating poorer visual outcomes in those with hypertension or inflammation.

Key Points

To evaluate the clinical risk factors, treatments, and visual outcomes of central retinal vein occlusion (CRVO) in patients younger than 40 years.
Conducted a retrospective monocentric case series evaluating young patients (< 40 years) diagnosed with CRVO.
Reviewed records for 54 eyes across 52 patients to assess demographic details, systemic and ocular risk factors, visual acuity (VA), and therapeutic interventions.
CRVO was idiopathic in 25.0% (13/52) of patients; primary risk factors included ocular hypertension (20.4%), inflammation (20.4%), high blood pressure (14.8%), and coagulation abnormalities (11.1%).
Final visual acuity was significantly lower in patients with high blood pressure (p = 0.03) and inflammation (p = 0.04) compared to patients without identified risk factors.
Therapeutic interventions included intravitreal injections in 42.6% (23/54) of eyes and panretinal photocoagulation in 35.2% (19/54) of eyes.

Cite This Study

Berguig et al. (2023) studied this question.

synapsesocial.com/papers/6a8c56d83e9737de6060ea9b https://doi.org/10.3389/fmed.2023.1180234

View Full Paper

Ask AI

Bookmark

August 4, 2023Frontiers in MedicineOpen Access

Central retinal vein occlusion in young population: risk factors and outcomes

View Full Paper

Ask AI

Bookmark

Authors

JBJordan BerguigFondation de Rothschild YAYoussef AbdelmassihSaint Joseph University GAGeorges AzarFondation de Rothschild

Discussion

Member takes

Implication

Retrospective case series reveals identifiable risk factors in most young central retinal vein occlusion cases, indicating poorer visual outcomes in those with hypertension or inflammation.

Key Points

To evaluate the clinical risk factors, treatments, and visual outcomes of central retinal vein occlusion (CRVO) in patients younger than 40 years.
Conducted a retrospective monocentric case series evaluating young patients (< 40 years) diagnosed with CRVO.
Reviewed records for 54 eyes across 52 patients to assess demographic details, systemic and ocular risk factors, visual acuity (VA), and therapeutic interventions.
CRVO was idiopathic in 25.0% (13/52) of patients; primary risk factors included ocular hypertension (20.4%), inflammation (20.4%), high blood pressure (14.8%), and coagulation abnormalities (11.1%).
Final visual acuity was significantly lower in patients with high blood pressure (p = 0.03) and inflammation (p = 0.04) compared to patients without identified risk factors.
Therapeutic interventions included intravitreal injections in 42.6% (23/54) of eyes and panretinal photocoagulation in 35.2% (19/54) of eyes.

Cite This Study

Berguig et al. (2023) studied this question.

synapsesocial.com/papers/6a8c56d83e9737de6060ea9b https://doi.org/10.3389/fmed.2023.1180234

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark